Bay Street News

Healthcare Realty Trust Reports Results For the Third Quarter

NASHVILLE, Tenn., Oct. 30, 2024 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2024. Net (loss) income attributable to common stockholders for the three months ended September 30, 2024 was $(93.0) million, or $(0.26) per diluted common share.

KEY THIRD QUARTER HIGHLIGHTS      
CAPITAL ALLOCATION      
MULTI-TENANT OCCUPANCY AND ABSORPTION
    3Q 2024 YTD 2024
  Absorption (SF) 158,720 341,473
  Change in occupancy (bps) + 49 + 106
SAME STORE      
BALANCE SHEET        
DIVIDEND        
GUIDANCE        
        EXPECTED 2024
    ACTUAL   PRIOR   CURRENT
    3Q 2024 YTD   LOW HIGH   LOW HIGH
  Earnings per share $ (0.26 ) $ (1.49 )   $ (1.50 ) $ (1.40 )   $ (1.60 ) $ (1.59 )
  NAREIT FFO per share $ 0.21   $ 0.23     $ 0.77   $ 0.82     $ 0.58   $ 0.59  
  Normalized FFO per share $ 0.39   $ 1.16     $ 1.53   $ 1.58     $ 1.55   $ 1.56  

The 2024 annual guidance range reflects the Company’s view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company’s guidance does not contemplate impacts from gains or losses from
dispositions, potential impairments, or debt extinguishment costs, if any. There can be no assurance that the Company’s actual results will not be materially higher or lower than these expectations. If actual results vary from these assumptions, the Company’s expectations may change.

EARNINGS CALL        

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty’s portfolio includes over 650 properties totaling nearly 40 million square feet concentrated in 15 growth markets.

Additional information regarding the Company, including this quarter’s operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: the Company’s expected results may not be achieved; failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A – Risk Factors, in the Company’s 2023 Annual Report on Form 10-K and in its other filings with the SEC.

Consolidated Balance Sheets
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
ASSETS          
  3Q 2024 2Q 2024 1Q 2024 4Q 2023 3Q 2023
Real estate properties          
Land $ 1,195,116   $ 1,287,532   $ 1,342,895   $ 1,343,265   $ 1,387,821  
Buildings and improvements   10,074,504     10,436,218     10,902,835     10,881,373     11,004,195  
Lease intangibles   718,343     764,730     816,303     836,302     890,273  
Personal property   9,246     12,501     12,720     12,718     12,686  
Investment in financing receivables, net   123,045     122,413     122,001     122,602     120,975  
Financing lease right-of-use assets   77,728     81,401     81,805     82,209     82,613  
Construction in progress   125,944     97,732     70,651     60,727     85,644  
Land held for development   52,408     59,871     59,871     59,871     59,871  
Total real estate investments   12,376,334     12,862,398     13,409,081     13,399,067     13,644,078  
Less accumulated depreciation and amortization   (2,478,544 )   (2,427,709 )   (2,374,047 )   (2,226,853 )   (2,093,952 )
Total real estate investments, net   9,897,790     10,434,689     11,035,034     11,172,214     11,550,126  
Cash and cash equivalents1   22,801     137,773     26,172     25,699     24,668  
Assets held for sale, net   156,218     34,530     30,968     8,834     57,638  
Operating lease right-of-use assets   259,013     261,976     273,949     275,975     323,759  
Investments in unconsolidated joint ventures   417,084     374,841     309,754     311,511     325,453  
Other assets, net and goodwill   491,679     559,818     605,047     842,898     822,084  
Total assets $ 11,244,585   $ 11,803,627   $ 12,280,924   $ 12,637,131   $ 13,103,728  
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
  3Q 2024 2Q 2024 1Q 2024 4Q 2023 3Q 2023
Liabilities          
Notes and bonds payable $ 4,957,796   $ 5,148,153   $ 5,108,279   $ 4,994,859   $ 5,227,413  
Accounts payable and accrued liabilities   197,428     195,884     163,172     211,994     204,947  
Liabilities of properties held for sale   7,919     1,805     700     295     3,814  
Operating lease liabilities   229,925     230,601     229,223     229,714     273,319  
Financing lease liabilities   71,887     75,199     74,769     74,503     74,087  
Other liabilities   180,283     177,293     197,763     202,984     211,365  
Total liabilities   5,645,238     5,828,935     5,773,906     5,714,349     5,994,945  
           
Redeemable non-controlling interests   3,875     3,875     3,880     3,868     3,195  
           
Stockholders’ equity          
Preferred stock, $0.01 par value; 200,000 shares authorized                    
Common stock, $0.01 par value; 1,000,000 shares authorized   3,558     3,643     3,815     3,810     3,809  
Additional paid-in capital   9,198,004     9,340,028     9,609,530     9,602,592     9,597,629  
Accumulated other comprehensive (loss) income   (16,963 )   6,986     4,791     (10,741 )   17,079  
Cumulative net income attributable to common stockholders   481,155     574,178     717,958     1,028,794     1,069,327  
Cumulative dividends   (4,150,328 )   (4,037,693 )   (3,920,199 )   (3,801,793 )   (3,684,144 )
Total stockholders’ equity   5,515,426     5,887,142     6,415,895     6,822,662     7,003,700  
Non-controlling interest   80,046     83,675     87,243     96,252     101,888  
Total Equity   5,595,472     5,970,817     6,503,138     6,918,914     7,105,588  
Total liabilities and stockholders’ equity $ 11,244,585   $ 11,803,627   $ 12,280,924   $ 12,637,131   $ 13,103,728  
                               
1 2Q 2024 cash and cash equivalents includes $96.0 million of proceeds held in a cash escrow account from a portfolio disposition that closed on June 28, 2024 and was received by the Company on July 1, 2024.
   
Consolidated Statements of Income
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
           
  3Q 2024 2Q 2024 1Q 2024 4Q 2023 3Q 2023
Revenues          
Rental income 1 $ 306,499   $ 308,135   $ 318,076   $ 322,076   $ 333,335  
Interest income   3,904     3,865     4,538     4,422     4,264  
Other operating   5,020     4,322     4,191     3,943     4,661  
    315,423     316,322     326,805     330,441     342,260  
Expenses          
Property operating   120,232     117,719     121,078     121,362     131,639  
General and administrative   20,124     14,002     14,787     14,609     13,396  
Normalizing items 2   (6,861 )           (1,445 )    
Normalized general and administrative   13,263     14,002     14,787     13,164     13,396  
Transaction costs   719     431     395     301     769  
Merger-related costs               1,414     7,450  
Depreciation and amortization   163,226     173,477     178,119     180,049     182,989  
    304,301     305,629     314,379     317,735     336,243  
Other income (expense)          
Interest expense before merger-related fair value   (50,465 )   (52,393 )   (50,949 )   (52,387 )   (55,637 )
Merger-related fair value adjustment   (10,184 )   (10,064 )   (10,105 )   (10,800 )   (10,667 )
Interest expense   (60,649 )   (62,457 )   (61,054 )   (63,187 )   (66,304 )
Gain on sales of real estate properties and other assets   39,310     38,338     22     20,573     48,811  
Gain on extinguishment of debt                   62  
Impairment of real estate assets and credit loss reserves   (84,394 )   (132,118 )   (15,937 )   (11,403 )   (56,873 )
Impairment of goodwill           (250,530 )        
Equity income (loss) from unconsolidated joint ventures   208     (146 )   (422 )   (430 )   (456 )
Interest and other (expense) income, net   (132 )   (248 )   275     65     139  
    (105,657 )   (156,631 )   (327,646 )   (54,382 )   (74,621 )
Net (loss) income $ (94,535 ) $ (145,938 ) $ (315,220 ) $ (41,676 ) $ (68,604 )
Net loss (income) attributable to non-controlling interests   1,512     2,158     4,384     1,143     760  
Net (loss) income attributable to common stockholders $ (93,023 ) $ (143,780 ) $ (310,836 ) $ (40,533 ) $ (67,844 )
           
           
Basic earnings per common share $ (0.26 ) $ (0.39 ) $ (0.82 ) $ (0.11 ) $ (0.18 )
Diluted earnings per common share $ (0.26 ) $ (0.39 ) $ (0.82 ) $ (0.11 ) $ (0.18 )
           
Weighted average common shares outstanding – basic   358,960     372,477     379,455     379,044     378,925  
Weighted average common shares outstanding – diluted 3   358,960     372,477     379,455     379,044     378,925  
1 In 2Q 2024, rental income was reduced by $3.0 million for Steward Health revenue reserves. This consisted of $2.2 million for April and prepetition rent for May as well as $0.8 million for March. In addition, the Company reversed $2.2 million of straight-line rent receivable against rental income.
2 3Q 2024 and 4Q 2023 normalizing items primarily include severance-related costs.
3 Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company’s operating partnership (“OP”), totaling 3,649,637 units were not included.
   
Reconciliation of FFO, Normalized FFO and FAD 1,2,3
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
           
  3Q 2024 2Q 2024 1Q 2024 4Q 2023 3Q 2023
Net loss attributable to common stockholders $ (93,023 ) $ (143,780 ) $ (310,836 ) $ (40,533 ) $ (67,844 )
Net loss attributable to common stockholders/diluted share3 $ (0.26 ) $ (0.39 ) $ (0.82 ) $ (0.11 ) $ (0.18 )
           
Gain on sales of real estate assets   (39,148 )   (33,431 )   (22 )   (20,573 )   (48,811 )
Impairments of real estate assets   37,632     120,917     15,937     11,403     56,873  
Real estate depreciation and amortization   167,821     177,350     181,161     182,272     185,143  
Non-controlling loss from operating partnership units   (1,372 )   (2,077 )   (4,278 )   (491 )   (841 )
Unconsolidated JV depreciation and amortization   5,378     4,818     4,568     4,442     4,421  
FFO adjustments $ 170,311   $ 267,577   $ 197,366   $ 177,053   $ 196,785  
FFO adjustments per common share – diluted $ 0.47   $ 0.71   $ 0.51   $ 0.46   $ 0.51  
FFO $ 77,288   $ 123,797   $ (113,470 ) $ 136,520   $ 128,941  
FFO per common share – diluted4 $ 0.21   $ 0.33   $ (0.30 ) $ 0.36   $ 0.34  
           
Transaction costs   719     431     395     301     769  
Merger-related costs               1,414     7,450  
Lease intangible amortization   (10 )   129     175     261     213  
Non-routine legal costs/forfeited earnest money received   306     465         (100 )    
Debt financing costs                   (62 )
Restructuring and severance-related charges   6,861             1,445      
Credit losses and gains on other assets, net5   46,600     8,525              
Impairment of goodwill           250,530          
Merger-related fair value adjustment   10,184     10,064     10,105     10,800     10,667  
Unconsolidated JV normalizing items6   101     89     87     89     90  
Normalized FFO adjustments $ 64,761   $ 19,703   $ 261,292   $ 14,210   $ 19,127  
Normalized FFO adjustments per common share – diluted $ 0.18   $ 0.05   $ 0.68   $ 0.04   $ 0.05  
Normalized FFO $ 142,049   $ 143,500   $ 147,822   $ 150,730   $ 148,068  
Normalized FFO per common share – diluted $ 0.39   $ 0.38   $ 0.39   $ 0.39   $ 0.39  
           
Non-real estate depreciation and amortization   276     313     485     685     475  
Non-cash interest amortization, net7   1,319     1,267     1,277     1,265     1,402  
Rent reserves, net8   (27 )   1,261     (151 )   1,404     442  
Straight-line rent income, net   (5,771 )   (6,799 )   (7,633 )   (7,872 )   (8,470 )
Stock-based compensation   4,064     3,383     3,562     3,566     2,556  
Unconsolidated JV non-cash items9   (376 )   (148 )   (122 )   (206 )   (231 )
Normalized FFO adjusted for non-cash items   141,534     142,777     145,240     149,572     144,242  
2nd generation TI   (16,951 )   (12,287 )   (20,204 )   (18,715 )   (21,248 )
Leasing commissions paid   (10,266 )   (10,012 )   (15,215 )   (14,978 )   (8,907 )
Building capital   (7,389 )   (12,835 )   (5,363 )   (17,393 )   (14,354 )
Total maintenance capex   (34,606 )   (35,134 )   (40,782 )   (51,086 )   (44,509 )
FAD $ 106,928   $ 107,643   $ 104,458   $ 98,486   $ 99,733  
Quarterly/dividends and OP distributions $ 113,770   $ 118,627   $ 119,541   $ 118,897   $ 119,456  
FFO wtd avg common shares outstanding – diluted10   363,370     376,556     383,413     383,326     383,428  
1 Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
2 FFO, Normalized FFO and Funds Available for Distribution (“FAD”) do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company’s operating performance or as alternatives to cash flow as measures of liquidity.
3 Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.
4 For 1Q 2024, basic weighted average common shares outstanding was the denominator used in the per share calculation.
5 3Q 2024 includes $46.8 million of credit loss reserves and $0.2 million gain on other assets. 2Q 2024 includes $11.2 million of credit loss reserves and $2.2 million write-off of prior period Steward Health straight-line rent, offset by $4.9 million gain on other assets.
6 Includes the Company’s proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
7 Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
8 2Q 2024 includes $0.8 million related to the Steward Health revenue reserve for March.
9 Includes the Company’s proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
10 The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 760,552 for the three months ended September 30, 2024. Also includes the diluted impact of 3,649,637 OP units outstanding.
   
Reconciliation of Non-GAAP Measures
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA – UNAUDITED
 

Management considers funds from operations (“FFO”), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution (“FAD”) to be useful non-GAAP measures of the Company’s operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company’s business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company’s financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company’s liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company’s needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company’s definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income and less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290


Bay Street News